Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Enhanced Ω3 is a patented monoglyceride omega-3 fatty acid researched and developed in Canada. The innovative MaxSimil delivery system was shown to have superior absorption as compared to leading brands of ethyl ester(EE) or reconstituted triglyceride (rTG) fish oils. IHN’
IHN’s Enhanced Ω3 is a patented monoglyceride omega-3 fatty acid researched and developed in Canada. The innovative MaxSimil delivery system was shown to have superior absorption as compared to leading brands of ethyl ester (EE) or reconstituted triglyceride (rTG) fish oils. The benefits of Omega-3 fatty acids as a food-based therapy are extremely well researched and documented. Clear indications include but are not limited to: cellular anti-oxidation and anti-inflammatory properties. Clinical expertise, documented evidence and patient compliance/value are three key factors crucial in the selection of the appropriate omega 3 fatty acid product. Most often patient compliance hinges solely on their individual consuming experience. Incomplete digestion of an omega 3 product leading to repeat (fish burp) is a common complaint and a leading factor in poor compliance of fish oil supplementation. Enhanced Ω3 was designed with clinicians and patients in mind; the natural emulsification of Enhanced Ω3 monoglyceride fish oil bypasses the digestive track and facilitates its absorption into the body. Clinically, Enhanced O3 demonstrated strong absorption properties even in the absence of any digestive enzymes, a 3X greater absorption rate than standard ethyl ester or reconstituted triglyceride fish oils and allows for increased patient compliance through modest daily serving requirements.
Enhanced Ω3 is a patented monoglyceride omega-3 fatty acid researched and developed in Canada. The innovative MaxSimil delivery system was shown to have superior absorption as compared to leading brands of ethyl ester(EE) or reconstituted triglyceride (rTG) fish oils. IHN’
IHN’s Enhanced Ω3 is a patented monoglyceride omega-3 fatty acid researched and developed in Canada. The innovative MaxSimil delivery system was shown to have superior absorption as compared to leading brands of ethyl ester (EE) or reconstituted triglyceride (rTG) fish oils. The benefits of Omega-3 fatty acids as a food-based therapy are extremely well researched and documented. Clear indications include but are not limited to: cellular anti-oxidation and anti-inflammatory properties. Clinical expertise, documented evidence and patient compliance/value are three key factors crucial in the selection of the appropriate omega 3 fatty acid product. Most often patient compliance hinges solely on their individual consuming experience. Incomplete digestion of an omega 3 product leading to repeat (fish burp) is a common complaint and a leading factor in poor compliance of fish oil supplementation. Enhanced Ω3 was designed with clinicians and patients in mind; the natural emulsification of Enhanced Ω3 monoglyceride fish oil bypasses the digestive track and facilitates its absorption into the body. Clinically, Enhanced O3 demonstrated strong absorption properties even in the absence of any digestive enzymes, a 3X greater absorption rate than standard ethyl ester or reconstituted triglyceride fish oils and allows for increased patient compliance through modest daily serving requirements.